Stockscreener 앱 받기
17.59
1.21%
0.21
시간 외 거래:
17.59
전일 마감가:
$17.38
열려 있는:
$17.1
하루 거래량:
537.88K
Relative Volume:
0.79
시가총액:
$900.90M
수익:
$379.81M
순이익/손실:
$-21.35M
주가수익비율:
-44.61
EPS:
-0.3943
순현금흐름:
$35.44M
1주 성능:
+6.93%
1개월 성능:
-11.47%
6개월 성능:
+20.56%
1년 성능:
-8.24%
1일 변동 폭
$16.86
$17.83
1주일 범위
$16.46
$17.83
52주 변동 폭
$10.96
$21.48
Caredx Inc Stock (CDNA) Company Profile
명칭
Caredx Inc
전화
415-287-2300
주소
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
17.59 | 890.14M | 379.81M | -21.35M | 35.44M | -0.3943 |
|
TMO
Thermo Fisher Scientific Inc
|
470.21 | 172.63B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.11 | 135.42B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
579.85 | 45.95B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.75 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
299.57 | 28.94B | 3.17B | 642.63M | 516.49M | 10.77 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-06 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2025-08-26 | 개시 | William Blair | Mkt Perform |
| 2025-01-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | 개시 | Wells Fargo | Underweight |
| 2024-08-19 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-05-13 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2023-11-09 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-03-07 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2023-03-03 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2021-07-20 | 재개 | BTIG Research | Buy |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-02-26 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-08 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-05 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-26 | 개시 | BTIG Research | Buy |
| 2020-06-19 | 재확인 | H.C. Wainwright | Buy |
| 2019-10-01 | 재개 | Craig Hallum | Buy |
| 2019-05-09 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | 개시 | Jefferies | Buy |
| 2018-10-23 | 재개 | Raymond James | Strong Buy |
| 2018-09-18 | 재확인 | H.C. Wainwright | Neutral |
| 2017-11-27 | 개시 | H.C. Wainwright | Buy |
| 2016-06-14 | 재확인 | Mizuho | Buy |
| 2015-09-29 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | 개시 | Craig Hallum | Buy |
| 2015-03-18 | 재확인 | Mizuho | Buy |
모두보기
Caredx Inc 주식(CDNA)의 최신 뉴스
CareDx (CDNA) Q4 earnings miss estimates - MSN
CDNA,SPOK Options - Finviz
Stock Analysis: Should you avoid CareDx Inc stock right now2026 Volatility Report & Growth Focused Stock Reports - baoquankhu1.vn
Trend Review: Should you avoid CareDx Inc stock right now2026 Bull vs Bear & Proven Capital Preservation Methods - baoquankhu1.vn
CareDx introduces VANTx AI platform for complex transplant datasets - MSN
Fred Alger Management LLC Sells 304,736 Shares of CareDx, Inc. $CDNA - MarketBeat
CareDx rebounds as draft LCD suggests no change in coverage - MSN
How The CareDx (CDNA) Story Is Shifting With CMS LCD Uncertainty And New Guidance - Yahoo Finance
Bamco Inc. NY Has $45.88 Million Stake in CareDx, Inc. $CDNA - MarketBeat
Braidwell LP Makes New Investment in CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. $CDNA Shares Purchased by ArrowMark Colorado Holdings LLC - MarketBeat
Prosight Management LP Grows Stock Holdings in CareDx, Inc. $CDNA - MarketBeat
Portolan Capital Management LLC Grows Stake in CareDx, Inc. $CDNA - MarketBeat
(CDNA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
CareDx raises 2025 revenue guidance to $372M–$376M with robust RCM gains and new product launches - MSN
CareDx Launches VANTx AI Solution for Advanced Transplant Data Analysis - Bitget
CareDx Introduces VANTx AI Platform for Complex Transplant Datasets - Zacks Investment Research
CareDx reports positive data for AlloHeme in AML and MDS post HCT - MSN
CareDx wins preliminary court approval for derivative settlement - MSN
CDNA PE Ratio & Valuation, Is CDNA Overvalued - Intellectia AI
CareDx Details Transplant+ Roadmap, AlloHeme Timeline, and 2026 Outlook at Raymond James Conference - MarketBeat
Paragon Associates & Paragon Associates II Joint Venture Buys 205,597 Shares of CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. (NASDAQ:CDNA) Given Consensus Rating of "Hold" by Analysts - MarketBeat
CareDx Q4 2025 earnings preview - MSN
CareDx launches AI platform for transplant research By Investing.com - Investing.com Australia
CareDx Earnings Call Highlights Growth Amid Reimbursement Risks - TipRanks
CareDx launches AI platform for transplant research - Investing.com
CareDx (CDNA) Introduces VANTx: A Revolutionary AI Data Platform for Transplants - GuruFocus
FinancialContentCareDx Announces VANTx™, an AI‑Powered Clinical Data & Analytics Platform Built on CareDx’s Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets - FinancialContent
Royce & Associates LP Has $5.88 Million Stake in CareDx, Inc. $CDNA - MarketBeat
First Eagle Investment Management LLC Buys 96,123 Shares of CareDx, Inc. $CDNA - MarketBeat
ARK Investment Management LLC Buys 70,468 Shares of CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. $CDNA Shares Bought by Amova Asset Management Americas Inc. - MarketBeat
Caredex Stock Quote, Share Price, News and Analysis - Longbridge
(CDNA) Risk Channels and Responsive Allocation - Stock Traders Daily
CareDx Issues Inducement Grants With Stock Options and RSUs for New Employees - geneonline.com
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Joplin Globe
CDNA SEC FilingsCaredx 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and Atai Beckley N.V. (ATAI) - The Globe and Mail
BTIG Raises CareDx (CDNA) Price Target to $26.00, Maintains Buy Rating | CDNA Stock News - GuruFocus
CareDx (CDNA) Returns To Q4 Loss As Revenue Growth Tests Bullish Narratives - simplywall.st
BTIG raises CareDx stock price target to $26 on strong Q4 results - Investing.com Canada
CareDx, Inc Q4 2025 Earnings Call Summary - Yahoo Finance
BTIG raises CareDx stock price target to $26 on strong Q4 results By Investing.com - Investing.com South Africa
CareDx (CDNA) grows 2025 revenue 14% and guides higher for 2026 - Stock Titan
CareDx: Conservative Revenue Upside Offset by Weaker Margins and Coverage Uncertainty Justifying Hold Rating - TipRanks
CareDx Names COO to Additional CFO Post - Contract Pharma
CareDx (CDNA) Receives Rating Update: Wells Fargo Raises Price T - GuruFocus
CareDx (NASDAQ:CDNA) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
CareDx (NASDAQ:CDNA) Shares Gap Down After Earnings Miss - MarketBeat
CareDx, Inc (NASDAQ:CDNA) Q4 2025 Earnings Call Transcript - Insider Monkey
Caredx Inc (CDNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.55%
2.50%
자본화:
|
볼륨(24시간):